Literature DB >> 6238957

Defective processing of keratan sulfate in macular corneal dystrophy.

K Nakazawa, J R Hassell, V C Hascall, L S Lohmander, D A Newsome, J Krachmer.   

Abstract

Macular corneal dystrophy is a human genetic disorder characterized by corneal opacities that arise, in part, from a failure to synthesize mature keratan sulfate proteoglycans. The macromolecules in macular corneas and in keratoconus corneas, an abnormality not involving proteoglycans, were biosynthetically labeled with [3H]mannose and [14C]glucosamine in organ culture, and the keratan sulfate proteoglycans were immunoprecipitated with antibodies against the protein core of monkey keratan sulfate proteoglycan. The chondroitin sulfate proteoglycans, which did not react with the antibody, were oversulfated in corneas from patients with macular corneal dystrophy. Characterization of the immunoprecipitates showed that macular corneas did not make keratan sulfate proteoglycan but did synthesize an immunoreactive glycoprotein in nearly equal amounts as keratan sulfate proteoglycan was synthesized by the keratoconus cornea. The oligosaccharides on the immunoprecipitated macular glycoprotein appeared to be normal. However, the macromolecules contained an unsulfated glycoconjugate that was nearly as large as the normal keratan sulfate chains isolated from the keratoconus keratan sulfate-proteoglycan and contained the same relative proportions of labeled glucosamine, mannose, and fucose. This glycoconjugate was resistant to digestion with keratanase. These observations indicate that macular corneal dystrophy is caused by an error in the synthesis of keratan sulfate, possibly involving the specific sulfotransferases involved in sulfation of the lactosaminoglycan backbone of the chains.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238957

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome.

Authors:  E Quentin; A Gladen; L Rodén; H Kresse
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  Cloning and chromosomal localization of mouse keratocan, a corneal keratan sulfate proteoglycan.

Authors:  J R Dunlevy; S Chakravarti; P Gyalzen; J P Vergnes; J R Hassell
Journal:  Mamm Genome       Date:  1998-04       Impact factor: 2.957

Review 3.  Golgi post-translational modifications and associated diseases.

Authors:  Sven Potelle; André Klein; François Foulquier
Journal:  J Inherit Metab Dis       Date:  2015-05-13       Impact factor: 4.982

4.  Characterization of a non-reducing terminal fragment from bovine articular cartilage keratan sulphates containing alpha(2-3)-linked sialic acid and alpha(1-3)-linked fucose. A sulphated variant of the VIM-2 epitope.

Authors:  G M Brown; T N Huckerby; B L Abram; I A Nieduszynski
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

5.  Glycosaminoglycan-free small proteoglycan core protein is secreted by fibroblasts from a patient with a syndrome resembling progeroid.

Authors:  H Kresse; S Rosthøj; E Quentin; J Hollmann; J Glössl; S Okada; T Tønnesen
Journal:  Am J Hum Genet       Date:  1987-09       Impact factor: 11.025

Review 6.  Proteoglycans in health and disease: structures and functions.

Authors:  A R Poole
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

7.  Linkage of a gene for macular corneal dystrophy to chromosome 16.

Authors:  J M Vance; F Jonasson; F Lennon; J Sarrica; K F Damji; J Stauffer; M A Pericak-Vance; G K Klintworth
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

8.  Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis.

Authors:  James L Funderburgh; Mary M Mann; Martha L Funderburgh
Journal:  J Biol Chem       Date:  2003-08-20       Impact factor: 5.157

9.  Novel mutations of CHST6 in Iranian patients with macular corneal dystrophy.

Authors:  Shiva Akbari Birgani; Zivar Salehi; Masoud Houshmand; Mohamad Javad Mohamadi; Leila Azizade Promehr; Zahra Mozafarzadeh
Journal:  Mol Vis       Date:  2009-02-18       Impact factor: 2.367

10.  Immunophenotypes of macular corneal dystrophy in India and correlation with mutations in CHST6.

Authors:  Afia Sultana; Gordon K Klintworth; Eugene J-M A Thonar; Geeta K Vemuganti; Chitra Kannabiran
Journal:  Mol Vis       Date:  2009-02-09       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.